• There are no suggestions because the search field is empty.

Life Sciences Blog

Whether you're in pharma, biotech, medical devices, or any other industry, our diverse services and expert guidance are designed to keep you informed and ahead of industry trends. Dive into our content and stay connected with the latest advancements and best practices.

Life Sciences Blog

Why-self-inspections-or-internal-audits-are-essential-for-your-QMS-1536x864
Circles_banner_news&events-1
Industry
Services
Filter
All
Services

GMP Annex 21: key requirements for importing medicines into the EU

In recent years, medicinal products for the EU market have been increasingly manufactured outside the EU. While this trend is particularly noticeable in...

Sub-visible particles in pharmaceutical products: understanding EP General Chapter 2.9.19

Ensuring the safety and quality of injectable pharmaceutical products is critical, and one key aspect of this is preventing particulate contamination

Analytical Method Transfer under GMP: tips & pitfalls

Analytical Method Transfers (AMTs) are a critical step in ensuring the reliable reproduction of validated analytical methods. These transfers occur...

How QPs Verify GMP Compliance for Non-EU Manufactured Products

Qualified Persons (QPs) play a crucial role in ensuring that medicinal products imported into the European Union (EU) meet Good Manufacturing...

Analytical Method Transfer: a practical step-by-step guide to compliance and efficiency

Did you know that performing an Analytical Method Transfer (AMT) can significantly benefit your laboratory? It’s a crucial process that allows...

ICP-MS vs ICP-OES analysis: choosing the right elemental impurity testing method

Elemental impurities in medicinal products and excipients are a major concern for regulatory authorities. The ICH Q3D guidelines set clear...

EU-QPPV registration and local pharmacovigilance contacts: what you need to know

In the European Union, ensuring the safety of human pharmaceutical products requires strict compliance with pharmacovigilance regulations. At the heart of...

Pharmacovigilance Agreements (PVA) simplified: key requirements and best practices for compliance

Pharmacovigilance Agreements (PVA), also known as Safety Data Exchange Agreements (SDEA), are essential legal contracts that outline the responsibilities for...

Container Closure Integrity Testing (CCIT): why it’s essential for pharmaceutical packaging

Imagine this: a life-saving drug reaches a patient, but due to a small, undetected defect in its packaging, the medicine is no longer sterile. The...

Quality Audits Management: Quality Audits managed according to QMS 

The Quality Audits should be managed according to the Quality Management System requirements , which should include: A risk-based planification...

Nitrosamine Impurities in Medicinal Products: Risks and Regulatory Insights 

The emergence of nitrosamine impurities In June 2018, regulatory authorities worldwide became aware of the presence of the nitrosamine ...

Operational software compliance that adds value: essential pharma Q&A

In pharmaceutical operations, effective software compliance is vital for regulatory adherence, data security, and the integrity of patient-critical...

Operational software compliance in pharma: a practical guide

In the pharmaceutical industry, maintaining software compliance is a continuous process that extends beyond initial validation. The computerized system...

Essential steps for pharma software compliance in the operational phase

In the pharmaceutical industry, ensuring compliance in software systems is vital for safeguarding data integrity, patient safety, and regulatory adherence....

How to avoid non-compliance in the pharmaceutical industry

Over the years the pharmaceutical industry has become one of the most highly regulated, second only to the nuclear and aerospace industries. The...

5 Key Toxicological Monitoring Tests for Regulatory Compliance

In an era where product safety and quality assurance are paramount,toxicological monitoring studieshave become essential for companies across industries....

Pharmacovigilance (PV) Safety Databases: Why They Matter and How to Choose the Right One

Pharmacovigilance is a cornerstone of patient safety and public health, ensuring that the benefits of medicines continue to outweigh their risks. Central to...

Understanding REACH Registration for Chemicals in Pharma

What is REACH, and Why is it Important for Pharma and Life Sciences?

Sterilization Validation: A Practical Guide to Ensuring Safety and Compliance

Sterilization validationis a vital process in the healthcare and pharmaceutical industries. It ensures that sterilization methods are not just...

15 Years of ATMPs – Reflecting on the Past, Shaping the Future

The Scientific Symposium on Advanced Therapy Medicinal Products (ATMPs), organized by the Committee for Advanced Therapies (CAT), marked a significant...

Maintaining Validation Excellence: Continuous Improvement Through Periodic Validation Reviews in Pharma

Technovigilance in Action: Safeguarding Health with Post-Market Surveillance of Medical Devices

With rapid advancements in medical technology reshaping healthcare, new devices and innovations are emerging faster than ever before. From innovative...

Why Combining Scripted and Unscripted Testing Boosts Your CSV Strategy

Imagine your pharmaceutical company has rolled out new software to manage your drug manufacturing processes, believing the system was fully validated....

The Rise of Knowledge Process Outsourcing in Drug Safety: Smarter Outsourcing for Safer Healthcare

As healthcare and patient safety become more important than ever, pharmaceutical companies are totally rethinking how they handle data and keep track of...

Stay Ahead of Compliance: How to Effectively Manage Your Yearly Audits

In the pharmaceutical and medical device industries, maintaining compliance with regulatory standards is crucial for ensuring product quality and...

Mastering EU Product Information: The Role of the EMA’s Linguistic Review Process in Centralised Procedures

For Medicinal Products, the Product Information (PI) is a key document that provides a summary of officially approved information for Healthcare...

Accurate but appealing: How our scientific copywriters and designers collaborate to create captivating content

The life sciences landscape is vast, complex, and rapidly changing, so it can be hard to navigate. Valuable knowledge and ground-breaking...

Outsourcing Internal Audits: Benefits and Process Optimization in Your Pharma Company

In the dynamic healthcare industry, maintaining efficiency and compliance isn’t just a necessity—it’s a strategic advantage. Have you ever...

Why scientists turn to communication: unlocking benefits for Life Sciences companies 

Scientists outside of science Many scientists catch the research bug as children. For some, the inciting incident was the gift of a...

The Risk of Benzene Contamination in Drug Products: What Manufacturers Need to Know

Benzene is a well-documented human carcinogen, and its presence in drug products poses a significant health risk. Benzene contamination can arise from...

Friability and disintegration for oral solid dose forms: the forgotten tests

Friability and disintegration testing are often overlooked during pharmaceutical development or testing; however, they play a certain role in getting...

Toxicological Assessment of Extractables and Leachables (E&L)

Ensuring the safety and efficacy of pharmaceutical products involves more than just the active ingredients. The materials used in packaging and delivery...

Analysing MHRA Performance: Clinical Trial and Amendment Applications in the UK

In 2023, assessment timelines for Clinical Trial Authorization (CTA) applications and substantial amendments by the MHRA were, in many cases, well beyond...

Article 31 Referrals in Pharmacovigilance: A Brief Overview

In the world of pharmaceuticals, ensuring the safety and efficacy of medicines is paramount. One crucial mechanism for maintaining these standards within...

How to Assess and Improve the Readability of Medicines: A Complete Guide | QbD Group

What is drug readability and why is it important? Readability refers to the clarity and ease with which a text can be read and understood. In the...

The Journey from Science to Story

So, you’ve made a huge breakthrough on a project you’ve been working on forever, or found that your drug can actually treat a whole other group of...

Analytical Method Transfer: Common Pitfalls and How to Avoid Them

Analytical method transfers (AMTs) are a critical step in the drug-development timeline. AMTs often occur due to sequential activities, such as...

Elevate Pharma Imports with EU GMP Annexes 16 and 21

In the world of pharma imports, maintaining Good Manufacturing Practice (GMP) standards is a shared responsibility that transcends borders. The...

The Holy Grail: Achieving Inspection Readiness

In a previous blog post, we talked about the various activities that take place during an inspection and how to deal with them as they occur....

Implementing PIC/S Standards in Hospital Cleanrooms: From Regulation to Application

Starting January 1, 2026, hospital pharmacies globally must comply with PIC/S standards for their pharmacy preparations, specifically requiring the...

Curb Your Enthusiasm – How to Avoid Rushing into Your Business Development Efforts with Unexpected Cost Consequences

Getting monetary value out of all your R&D efforts is key to the long-term success of your business. Launching products and services seems...

The Role of Artificial Intelligence (AI) in Pharmacovigilance in Europe: Advances and Legislation

The safety of medicines is a fundamental concern in the field of public health, and in Europe, pharmacovigilance plays a crucial role in ensuring...

Social Media in Pharmacovigilance: Harnessing Online Conversations for Drug Safety

Did you know millions of patients are already discussing medications and side effects online? Social media is revolutionizing pharmacovigilance,...

What to expect when being inspected?

In a previous blog post “Regulatory Inspection Readiness: A Proactive Approach to CAPA and Compliance” we talked about the steps to take after the...

SCADA Automation in Pharma: Boosting Efficiency and Compliance

Imagine a world where countless operators meticulously monitored dials and switches, ensuring the precise production of life-saving...

Impact of PDE values on cleaning validation design in pharmaceutical manufacturing

Toxicology is fundamental throughout the drug life cycle, beginning with the evaluation of active substances in animals during the pre-clinical...

Safeguarding Drugs: Controlling Elemental Impurities (ICH Q3D)

Elemental impurities might not be the first thing you think of when it comes to drug safety, but they are crucial to understand. These impurities ...

Regulatory Inspection Readiness: A Proactive Approach to CAPA and Compliance

“Send” – After weeks of collaboration with the operations team, legal advisors, and experts, a detailed response along with Corrective and...

Environmental Risk Assessments (ERA) in Pharma: Balancing Health & Environment

As we strive to improve our health with new medicines, it’s crucial we don’t forget the impact these advances could have on the environment. The...

Drug-Device Combination Products and Article 117: How to Stay Compliant?

With the 2017 Medical Devices Regulation (MDR) fully operational from May 26, 2021, Article 117 has brought significant changes. It now requires that the...

Patient Support Programs: Enhancing Patient Care through Pharmacovigilance

Patient Support Programs (PSPs), as outlined by the Good Pharmacovigilance Practices (GVP) Module VI, represent an organized system where marketing...

A Deeper Dive into the MHRA Good Pharmacovigilance Practice (GPvP) Inspection Metrics and Findings

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has been conducting Good Pharmacovigilance Practice (GPvP) inspections since 2003. Any...

MHRA to Launch RegulatoryConnect Portal in the UK: A New Era in Regulatory Management 

During a webinar held on March 12, 2024, they unveiled the features of Release 1 of this innovative portal, previously known as the “RMS” or “Regulatory...

ICH Q2(R2) Validation of Analytical Procedures: An Overview of the Revised Guideline

Introduction Did you know that the precision of analytical methods directly influences the safety and efficacy of pharmaceutical products? Understanding...

How to create a GMP-Compliant Stability Protocol?

Stability testing forms the cornerstone of pharmaceutical quality, ensuring that medicinal products retain their safety, efficacy, and quality throughout...

Toxicology Challenges in Pharma: How to Address Them?

Toxicology plays a pivotal role in the pharmaceutical industry, focusing on mitigating the adverse effects of substances on living organisms and their...

Quality and Regulatory Affairs: Key Elements of a Robust QMS in Pharma for Compliance and Success

In the complex and highly regulated world of pharmaceuticals, thesynergy between Quality and Regulatory Affairsis not just crucial, it’s indispensable....

Continuous manufacturing in the pharmaceutical industry: enhancing drug production

A significant shift towards continuous manufacturing (CM) is currently underway in the pharmaceutical industry. Unlike the more commonly used batch...

MHRA’s International Recognition Procedure Post Brexit: Navigating Medicinal Product Registration in the UK

One of the initial changes implemented by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) following Brexit was introducing a...

Qualifying a new GMP facility: from pitfalls to best practices

In pharmaceutical production, a GMP (Good Manufacturing Practices) facility stands as a testament to stringent quality control and precision....

Navigating Project Complexities: QbD’s Project Management Process for Qualification and Validation Projects

In the world of life sciences, ensuring the safety and efficacy of products is paramount. Qualification and validation projects play a pivotal role...

Importing medicinal products into the EU? A brief guide to EU GMP compliance.

In an era of increasing globalization, the pharmaceutical landscape is undergoing significant changes. This blog post offers a structured insight...

Computer Software Assurance (CSA) in Pharma Industry: First Steps to move from CSV to CSA 

In the rapidly evolving pharmaceutical industry, computerized systems play a vital role in drug development, manufacturing, quality control, and...

Understanding plasmids: small molecules with big implications

Plasmids are used in various research and biotechnology applications, such as gene therapy, vaccine development, and recombinant protein production.

Oncolytic viruses: the use for cancer immunotherapy

Immunotherapy has become an important therapeutic alternative to surgery, chemotherapy, and radiation in the fight against cancer. Oncolytic viruses

Paperless Validation in Pharma: embrace the future

Nowadays, pharmaceutical companies have an ever-increasing number of equipment, automation activities, and computerized systems to streamline their...

GMP-compliant design of climate or stability chambers: the key to ensuring product integrity

Stability testing serves as the backbone of regulatory compliance for pharmaceutical companies, providing crucial insights into the durability and...

4 Factors Influencing the Stability of Medicinal Products

Ensuring the stability of medicinal products is crucial for maintaining their effectiveness and safety throughout their shelf life. Numerous factors come...

Digital health in pharma: revolutionizing the industry from R&D to patient care

Digital health in pharma is not just an emerging trend; it’s shaping the future of the pharmaceutical industry. This evolution is altering the healthcare...

Mastering Cleanroom Qualification: navigating the latest regulatory updates 

In 2022, significant updates were made to the main standards that impact the qualification of cleanrooms. These updates include: {% module_block...

Computerized System Validation in clinical trials: key considerations

Computerized systems have become an integral part of clinical research, from data collection to analysis and reporting. However, ensuring the accuracy,...

The Importance of Stability Testing in Pharmaceutical Development

Stability testing plays a crucial role in the development of medicinal products, ensuring that they maintain their quality, safety, and efficacy throughout...

Pharma 4.0: The Future of Pharmaceutical Manufacturing

Industry 4.0 refers to the fourth industrial revolution, and within the pharmaceutical industry, there is a specific term called Pharma 4.0. It involves...

EudraLex Volume 4 Annex 11: compliance checklist and future prospects

What is EudraLex Volume 4 Annex 11? EudraLex Annex 11 serves as a reference document within the European Union‘s pharmaceutical industry. It provides...

A Deep Dive into Clinical Trials Regulations: Shifts and Strategies in the UK and EU

The last two years have seen significant changes in the approval management of clinical trials. In the UK, the Combine Review system became mandatory...

The EU Commission Proposes a General Reform of Pharmaceutical Legislation – What it Means for Patients and the Industry

On 26 April 2023, the European Commission adopted a proposal for a new Directive and a new Regulation that revise and replace: the existing general...

Automated software testing for the GxP world

Automated software testing is becoming increasingly crucial in the GxP world, where Pharma 4.0 is the future, the EU MDR is asserting its influence, and...

Analytical Method Validation: are your analytical methods suitable for intended use?

What is Analytical Method Validation? Analytical method validation is a critical process in the pharmaceutical, biotechnology, and food industries to...

What is the Agile model in Computerized System Validation? 

Pharmaceutical, clinical, MD, and IVD companies pursuing robustness in their software validation activities can use either the V-model or the Agile model

EU GMP Annex 1 Revision: Manufacture of Sterile Medicinal Products – Summary and first insights

EU GMP Annex 1’s revision – the 2022 update to ‘ Manufacture of Sterile Medicinal Products‘ – aimed to eliminate ambiguities and inconsistencies while...

UK’s medicines regulator announces IT roadmap

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) recently implemented a new organisational structure which aims to meet the additional...

7 key areas to focus on during internal or supplier audits 

Regulatory agencies require internal and supplier auditsin the pharmaceutical and medical device industry to ensure products are safe and effective....

8 steps to successfully respond to non-conformities in an inspection report  

Pharmaceutical companies are often inspected by competent authorities to verify the manufacturer’s compliance with regulatory requirements to ensure...

What is the GAMP 5 V-model in Computerized System Validation? 

Using software for your life sciences operations requires high integrity and security in the data processing. Your computer systems must be designed to...

Qualification of laboratory equipment: key considerations and challenges

The introduction of a new product into your company’s portfolio may require expanding your existing laboratories or even building a new laboratory to...

Annual Product Quality Review (APQR / PQR) in Pharma: importance, benefits & challenges

Current regulations require written documentation for all existing products in the company; this documentation is known as the A nnual Product Quality...

21 CFR Part 11 compliance checklist: does your system comply?

In the post-COVID pharmaceutical landscape, electronic records and signatures are indispensable, guided by the 21 CFR Part 11 compliance framework. This...

What is the purpose of Periodic Reviews in CSV?

Current regulations require that manufacturing processes in the pharmaceutical industry be validated, and once validated, they must be continuously...

The importance of high-quality gas distribution networks for critical process gases, even in the early development phase

Although no single best practice, standard, or guideline has been specifically enforced, competent authorities, such as the FDA, are increasingly...

GAMP 5 guide 2nd edition: what’s new?

GAMP 5, which stands for “Good Automated Manufacturing Processes”, is an approach that has been widely used in life science industries for validating...

Why self-inspections or internal audits are essential for your QMS

Any company in the pharmaceutical or medical device industry with a certified GMP, GDP or ISO 13485 Quality Management System must conduct self-inspections...

Medicine advertising in Belgium: a brief regulatory overview

In Belgium, medicine advertising is subject to specific legislation. The objective is to ensure the rational use of medicines, based on accurate and...

6 common myths about life sciences consultancy

A job in life sciences consultancy offers plenty of challenges, variety, career opportunities, and growth, but it is still shrouded in myth and mystery

Compressed gases in pharmaceutical manufacturing: best practices in microbial monitoring

Compressed gas standards The latest draft of Annex 1, Manufacture of Sterile Medicinal Products, introduced the concept of a “contamination...

Data migration in CSV: definition, purpose, and best practices

Ever wondered why it is necessary – and sometimes absolutely essential – to perform a Data Migration in computer systems, applications or software,...

What is decommissioning in CSV?

Changes in business needs or technology are inevitable. They often lead to the retirement or “decommissioning” of computerized systems. ERP systems, for...

How to use electronic signatures in regulated industries?

During the pandemic, electronic signatures gained tremendous importance for companies in heavily regulated industries. After all, a correctly...

EDQM and the CEP of the future 

Before marketing a medicinal product, pharmaceutical companies must obtain a marketing authorization (MA) from the respective licensing authority. In...

CAR-T cell therapy: main components, manufacturing, and prospects

CAR-T cell therapy, a groundbreaking advancement in the pharmaceutical industry over the last 20 years, exemplifies the innovative strides made in areas...

GAMP categories for computerized systems: what are they and what are they for?

New to validating computerized systems? If so, it might be difficult to get started on this type of validation. Why? Because, even if you have experience...

Dendritic (DC) cells: effective sentinels for immunotherapies

Dendritic cells (DCs) are crucial cells in the initiation and regulation of the adaptive immune response. These leukocytes form a link between the...

Natural Killer (NK) cells: a major breakthrough in the field of ATMPs

Natural Killer cells or NK cells are large lymphocytes (white blood cells) that play a crucial role in our innate immune system. The innate immune system,...

ATMPs: translating the expertise into a GMP process

In the field of regenerative medicine, advanced therapy medicinal products (ATMPs) represent the next generation of medicines. It is, however, not...

Clinical Trials for ATMPs: which challenges to overcome?

T he global regenerative medicine market, including  direct-to-consumer stem cell therapy , is expected to reach $5.6 billion by 2025, according to a...

10 things you should know before validating Computerized Systems

Smart factories: How digital twins can strongly improve your ATMP manufacturing processes

Industry 4.0 is currently revolutionizing the design, manufacturing and services of healthcare applications. It includes the automation and...

Why QP challenges in ATMPs are different & what you need to know

QP challenges in ATMPs Advanced Therapeutic Medicinal Products are – by definition – ‘advanced’. In order to meet the new scientific progress,...

How do you reduce the Cost of Goods, which is key to affordable ATMPs?

Today, only 18 cell and gene therapies have made it to the FDA approved therapies list.Only 14have been approved for the European market. This means...

The key role of Regulatory Affairs in the pharmaceutical industry: from development to commercialization

Regulatory Affairs plays a crucial role in the pharmaceutical industry, especially during drug development: a lengthy, complex, and extremely costly but...

Is your ATMP platform robust enough to deal with material input variability?

Do you want to distinguish starting materials used for ATMPs from those used for transplants or transfusions? This distinction is made based on how the...

Quality by design methodology for the pharmaceutical industry

How to guarantee medicine quality and patient safety To explain the quality by design methodology, it’s important to first pay attention to how the quality...

Automation Pyramid – FAQ

What does an automation pyramid entail? An automation pyramid visualizes the integrated layers of technology used in manufacturing or industry combined...

What to focus on when validating a computer system? (3)

GxP Processes At first glance, business processes are not important from a regulatory point of view. However, it is necessary to assess them if the...

What to focus on when validating a computer system? (2)

When categorizing, GAMP5® takes two main aspects of a system into account: the complexity and the inherent risk. The more standard and tested software is, the...

ATMP manufacturing for the market: main hurdles to be tackled to ensure a high-quality end product.

Hurdles to be taken As ATMPs progress towards commercialization, engineering challenges increase along with the increased number of patients and collection...

What to focus on when validating a computer system

In our first blog we discussed the definitions of validation and computerized systems. Assessing the health of the system means checking whether the system...

Anything you need to know about ATMPs: FAQ

What is the definition of ATMP? From the website of EMA: Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on...

ATMPs in a nutshell: what you should know about classification, quality and go to market

Advanced therapy medicinal products (ATMP) is the group of therapies in which we use cells, genes, engineered tissues and combinations of the above with...

Artificial Intelligence in Advanced Therapy Medicinal Products

What are ATMPs and what are the challenges? According to the European Medicines Agency (EMA), ATMPs are ‘medicines for human use that are based on genes,...

Computer Systems: is Assurance the new Validation?

The past of Computer Systems Validation has served us well and provided us with the foundation of where we are today. But at some point, the past can become a...

Market release of vaccines: European Union versus the United States of America

First of all, let’s take a look at the manufacturing flow of vaccines. The production process consists of various stages. It all starts with the raw...

Technical Writing in Pharma and Biotech: Essential Tips

Imagine guiding someone through Excel’s myriad functions in a written manual. Where to begin? With basics like opening the program and creating...

Serialization in the EU can become a competitive advantage if you dare to innovate

Falsified medicines could seriously harm the health of patients and may even put their lives at risk. A counterfeit product can contain wrong dosages,...

EU GMP Annex I: Are we ready for the challenges posed after its revision?

After months of revision and many questions raised, it now appears that the time is coming to implement the new requirements contained in the revision of...

Updating Good Clinical Practice E6(R2)

Every day, patients around the world participate in clinical trials. Their contributions are crucial, as they ensure the progress of vital research....

Preparing for growing challenges in pharmaceutical serialization

Serialization is rapidly emerging in the pharmaceutical world. To fight counterfeit drugs, more and more governments demand that every single sales...

Antleron & QbD team up to create a landslide in healthcare

Some encounters have big consequences. When QbD’s CEO Bart Van Acker met Antleron co-founder Jan Schrooten at a Flanders.bio event, one thing soon led to...

Data integrity in the pharma industry – a short introduction

Over the last couple of years, the data integrity topic has received more and more attention. Recently, the American Food and Drug...
data-not-found No Blog Post Found!
circle-box